Home Trending Stocks Galectin Therapeutics Inc. (GALT) stock surges during pre-market trading. Here’s what you...

Galectin Therapeutics Inc. (GALT) stock surges during pre-market trading. Here’s what you should know?

Galectin Therapeutics Inc. (NASDAQ: GALT) stock declined by 15.24% at the last close whereas the GALT stock price gains by 10.07% in the pre-market trading session. Galectin Therapeutics is devoted to the development of new medicines to help people with chronic liver disease and cancer live better lives.

>> 7 Top Picks for the Post-Pandemic Economy << 

What is happening?

Galectin Therapeutics released top-line clinical results from the extension cohort of a Phase 1b clinical study of Belapectin, a galectin-3 inhibitor, in conjunction with KEYTRUDA (pembrolizumab) in patients with metastatic melanoma and head and neck cancer1, which was begun by the investigator. Dr. Brendan D. Curti who is well-known cancer and melanoma expert is in charge of the research.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Nine melanoma patients and five patients with head and neck squamous cell carcinoma malignancy were recruited in the extension trial. The group in this extension trial was severely pretreated with systemic therapy, including chemotherapy, immunotherapy with checkpoint inhibitors and cytokines, melanoma mutation-directed medicines, as well as surgery and radiation therapies, relative to the initial phase 1b patients. Patients also had a high rate of metastasis, with the lungs, soft tissues, and liver being the organs most commonly affected. Four of the nine melanoma patients had choroidal tumors as their original malignancy location, as well as liver metastases.

Dr. Brendan Curti, the Principal Investigator of the study, commented,

When patients in this extension cohort were enrolled, they had a much larger tumor burden than those in the original research, which he finds promising. The extension cohort’s findings indicate the need for a Phase 2 randomized controlled trial to further examine the benefit and immunological consequences of belapectin in conjunction with KEYTRUDA vs KEYTRUDA alone and to completely demonstrate the efficacy and immunological effects of this combination.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

Why did Scopus BioPharma Inc. (SCPS) stock couldn’t keep its positivity in the after-hours on Wednesday?

Scopus BioPharma Inc. (SCPS) shares plunged 8.40% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $5.56 per share. earlier...

Why did Etsy Inc. (ETSY) shares decline in the after-markets on Wednesday?

Etsy Inc. (ETSY) shares declined 13.81% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $174.20 per share. In the...

Here is why MicroVision Inc. (MVIS) stock surged in the after-hours on Wednesday?

MicroVision Inc. (MVIS) shares surged 14.98% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $14.05 per share. In the...

Related News

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam